But it can be seen that high expression of let-7a-2–3p was associated with mutation of CEBPA (P = 0.03, Table 1), which can be seen as a biomarker for favorable prognosis in CN-AML [19]. This evidence concerns the gene CEBPA and acute myeloid leukemia.